188 related articles for article (PubMed ID: 36994900)
1. Combining primary tumor features derived from conventional and contrast-enhanced ultrasound facilitates the prediction of positive axillary lymph nodes in Breast Imaging Reporting and Data System category 4 malignant breast lesions.
Du Y; Yi CB; Du LW; Gong HY; Ling LJ; Ye XH; Zong M; Li CY
Diagn Interv Radiol; 2023 May; 29(3):469-477. PubMed ID: 36994900
[TBL] [Abstract][Full Text] [Related]
2. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.
Du LW; Liu HL; Gong HY; Ling LJ; Wang S; Li CY; Zong M
Br J Radiol; 2021 Feb; 94(1118):20200874. PubMed ID: 32976019
[TBL] [Abstract][Full Text] [Related]
3. Combining the Ultrasound Features of Primary Tumor and Axillary Lymph Nodes Can Reduce False-Negative Rate during the Prediction of High Axillary Node Burden in BI-RADS Category 4 or 5 Breast Cancer Lesions.
Yi CB; Ding ZY; Deng J; Ye XH; Chen L; Zong M; Li CY
Ultrasound Med Biol; 2020 Aug; 46(8):1941-1948. PubMed ID: 32451195
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
[TBL] [Abstract][Full Text] [Related]
5. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Ultrasound Imaging in Breast Imaging-Reporting and Data System 4 Breast Lesions: A Prediction Model for Malignancy.
Li XL; Lu F; Zhu AQ; Du D; Zhang YF; Guo LH; Sun LP; Xu HX
Ultrasound Med Biol; 2020 Dec; 46(12):3188-3199. PubMed ID: 32896449
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging.
Guo W; Li F; Jia C; Wang T; Zhang X; Yao G; Shi X; Bai M
Br J Radiol; 2022 Aug; 95(1136):20220025. PubMed ID: 35604699
[TBL] [Abstract][Full Text] [Related]
8. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
9. Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications.
Cheng M; Tong W; Luo J; Li M; Liang J; Pan F; Pan J; Zheng Y; Xie X
Clin Radiol; 2020 Dec; 75(12):934-941. PubMed ID: 32814625
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced lymphatic US can improve the preoperative diagnostic performance for sentinel lymph nodes in early breast cancer.
Niu Z; Gao Y; Xiao M; Mao F; Zhou Y; Zhu Q; Jiang Y
Eur Radiol; 2023 Mar; 33(3):1593-1602. PubMed ID: 36152038
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses.
Niu Q; Zhao L; Wang R; Du L; Shi Q; Jia C; Li G; Jin L; Li F
Eur J Radiol; 2024 Apr; 173():111391. PubMed ID: 38422608
[TBL] [Abstract][Full Text] [Related]
12. The association between conventional ultrasound and contrast-enhanced ultrasound appearances and pathological features in small breast cancer.
Chen J; Li CX; Shao SH; Yao MH; Su YJ; Wu R
Clin Hemorheol Microcirc; 2022; 80(4):413-422. PubMed ID: 34842181
[TBL] [Abstract][Full Text] [Related]
13. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients.
Han X; Jin S; Yang H; Zhang J; Huang Z; Han J; He C; Guo H; Yang Y; Shan M; Zhang G
Br J Radiol; 2021 Sep; 94(1125):20210520. PubMed ID: 34415197
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive targeted contrast-enhanced ultrasonography for the work-up of Breast Imaging Reporting and Data System category 3 and 4 lesions.
Zhang XL; Guan J; Li MZ; Liu MJ; Guo Y; Zheng YL; Yang Z; Yang JY
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):485-91. PubMed ID: 27162117
[TBL] [Abstract][Full Text] [Related]
15. Redefining ultrasound appearance criteria of positive axillary lymph nodes.
Duchesne N; Jaffey J; Florack P; Duchesne S
Can Assoc Radiol J; 2005 Dec; 56(5):289-96. PubMed ID: 16579022
[TBL] [Abstract][Full Text] [Related]
16. Gail model and fifth edition of ultrasound BI-RADS help predict axillary lymph node metastasis in breast cancer-A multicenter prospective study.
Gao LY; Ran HT; Deng YB; Luo BM; Zhou P; Chen W; Zhang YH; Li JC; Wang HY; Jiang YX
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e71-e79. PubMed ID: 35593663
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of contrast-enhanced ultrasound in the differential diagnosis for breast lesions with inconsistent results on mammography and conventional ultrasound.
Shao SH; Li CX; Yao MH; Li G; Li X; Wu R
Clin Hemorheol Microcirc; 2020; 74(4):463-473. PubMed ID: 31868661
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram for Enhancing the Diagnostic Effectiveness of Solid Breast BI-RADS 3-5 Masses to Determine Malignancy Based on Imaging Aspects of Conventional Ultrasonography and Contrast-Enhanced Ultrasound.
Yan M; Peng C; He D; Xu D; Yang C
Clin Breast Cancer; 2023 Oct; 23(7):693-703. PubMed ID: 37394416
[TBL] [Abstract][Full Text] [Related]
19. Incorporating Contrast-Enhanced Ultrasound into the BI-RADS Scoring System Improves Accuracy in Breast Tumor Diagnosis: A Preliminary Study in China.
Xiao X; Dong L; Jiang Q; Guan X; Wu H; Luo B
Ultrasound Med Biol; 2016 Nov; 42(11):2630-2638. PubMed ID: 27544439
[TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison of perfluorobutane contrast-enhanced US and multiparametric MRI for breast cancer: a prospective, multicenter study.
Lang M; Liang P; Shen H; Li H; Yang N; Chen B; Chen Y; Ding H; Yang W; Ji X; Zhou P; Cui L; Wang J; Xu W; Ye X; Liu Z; Yang Y; Wei T; Wang H; Yan Y; Wu C; Wu Y; Shi J; Wang Y; Fang X; Li R; Yu J
Breast Cancer Res; 2023 May; 25(1):61. PubMed ID: 37254149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
